Renovion Announces Positive Top-Line Results from Phase 2 CLIMB Study of ARINA-1 (RVN-301) in Patients with Non-Cystic Fibrosis Bronchiectasis
Renovion Completes Enrollment of Adult Patients in Phase 2 CLIMB Study in Bronchiectasis
Interview with the Lung Transplant Foundation: Participating in a Lung Transplant Clinical Trial
First Patient Enrolled in Phase 3 Clinical Trial Evaluating ARINA-1 in Lung Transplant
Double breath of fresh air for Triangle startup: $15M in new cash, fast track status for treatment
Renovion Receives FDA Fast Track Designation for ARINA-1 for the Prevention of BOS Progression in LT
First Patient Enrolled in Phase 2 Clinical Study Evaluating ARINA-1 for the Treatment of NCFBE
Renovion Receives Notice of Study May Proceed Status for Lung Transplant Program
Marty Zamora, MD, joins Renovion, Inc. as Chief Medical Officer
